Drugs / Mometasonefluroate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06067100 | Jan 2024 → Jul 2026 overdue | — | Morten Hostrup, PhD | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mometasonefluroate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06067100 ↗ |
| Route | Inhaled | “acute inhalation of beta2-agonist indacaterol + mometasonefuroate” NCT06067100 ↗ |